當我們談到肥胖的危害，多數人首先想到的是糖尿病、高血壓、心臟病。但一個常被忽略的事實是：肥胖也是重要的致癌風險因子。
When we think about the dangers of obesity, most people first consider diabetes, hypertension, and heart disease. But an often-overlooked fact is: obesity is also a major cancer risk factor.
美國每年有約 10% 的新癌症診斷與過重或肥胖直接相關，肥胖癌症風險在特定癌種（如子宮內膜癌）更高達 50%。
Approximately 10% of new cancer diagnoses in the United States each year are directly linked to overweight or obesity. For certain cancer types — such as endometrial cancer — the obesity-cancer risk reaches as high as 50%.
2026 年 3 月發表於《美國醫學會期刊》（JAMA）的最新綜合回顧研究，系統性整理了肥胖與癌症之間的生物學機制，以及各種減重方式如何降低癌症風險的最新實證。以下用易懂的語言，帶您了解這項重要研究的核心發現。
A comprehensive review published in JAMA in March 2026 systematically summarizes the biological mechanisms linking obesity and cancer, and the latest evidence on how weight loss reduces cancer risk. Below, in plain language, are the key findings of this landmark study.
根據 JAMA 2026 年最新研究，關於肥胖與癌症的關係：
- 肥胖與 12 種癌症直接相關，佔美國每年新癌症診斷的 10%
- 肥胖透過五大生物機制促進腫瘤生長，包括慢性發炎、荷爾蒙失衡、DNA 損傷等
- 減重超過 10% 可有效降低癌症風險；代謝手術防癌效果最強，可降低 32% 的肥胖相關癌症發生率
Based on the JAMA 2026 study on the obesity-cancer relationship:
- Obesity is directly linked to 12 cancers, accounting for 10% of new U.S. cancer diagnoses annually
- Obesity promotes tumor growth via five biological mechanisms, including chronic inflammation, hormonal imbalance, and DNA damage
- Losing more than 10% of body weight significantly reduces cancer risk; bariatric surgery offers the strongest cancer-prevention effect, reducing obesity-related cancer incidence by 32%
肥胖與癌症：最新流行病學數據 Obesity & Cancer: Latest Epidemiological Data
目前全球超過 40 億人口屬於過重或肥胖，預計到 2035 年將超過 51% 的全球人口。隨著肥胖盛行率上升，肥胖相關癌症的發生率也同步攀升。
Currently, more than 4 billion people worldwide are overweight or obese, with projections suggesting over 51% of the global population will be affected by 2035. As obesity rates rise, obesity-related cancer incidence rises in parallel.
預估到 2050 年，全球每年新癌症病例將超過 3,500 萬例。BMI 與癌症的關係在多項大型研究中已獲確認——BMI 越高，多數肥胖相關癌症的風險越大。
By 2050, global annual new cancer cases are projected to exceed 35 million. The relationship between BMI and cancer has been confirmed across multiple large-scale studies — the higher the BMI, the greater the risk for most obesity-related cancers.
可歸因於過重或肥胖 of new U.S. cancer diagnoses
attributable to overweight/obesity
與肥胖直接相關 of endometrial cancer cases
directly linked to obesity
肥胖相關癌症種類 obesity-related cancer types
recognized by IARC
癌症發生率降幅 reduction in cancer incidence
at 10 years post-surgery
| 指標 | 數值 | 臨床意義 |
|---|---|---|
| 肥胖致癌比例 | 每年新癌症診斷的 10% | 僅次於吸菸，是第二大可預防致癌因素 |
| 子宮內膜癌歸因比例 | 最高達 50% | 停經後肥胖女性風險尤其顯著 |
| IARC 認定肥胖相關癌症 | 12 種（另有 3 種證據力略低） | 涵蓋消化系統、生殖系統、血液腫瘤等 |
| 代謝手術防癌效果 | 10 年癌症發生率降低 32% | 目前證據最強的減重防癌介入方式 |
研究同時發現，合併代謝症候群的過重肥胖族群（代謝不健康表型），罹患癌症的風險比單純體重過重但代謝正常者更高。
Research also shows that overweight/obese individuals with metabolic syndrome (the metabolically unhealthy phenotype) face higher cancer risk than those who are overweight but metabolically normal.
📖 延伸閱讀：健保減重手術申請條件與 BMI 資格一覽
📖 Further reading: NHI Bariatric Surgery Eligibility Criteria & BMI Requirements
哪 12 種癌症與肥胖相關？ Which 12 Cancers Are Linked to Obesity?
國際癌症研究機構（IARC）目前將以下癌症列為肥胖相關癌症，並獲充分流行病學與機制研究支持：
The International Agency for Research on Cancer (IARC) currently recognizes the following as obesity-related cancers, supported by robust epidemiological and mechanistic evidence:
除上述 12 種外，肥胖也與以下癌症有關聯性，但目前證據強度略低：
In addition to these 12, obesity also shows associations with the following cancers, though with slightly weaker current evidence:
BMI 與癌症風險：各癌種具體數據 BMI & Cancer Risk: Data by Cancer Type
BMI 升高與肥胖相關癌症的發生率呈線性正相關。以下為主要癌種的風險增幅：
Higher BMI correlates linearly with increased obesity-related cancer incidence. Below is the risk increase for major cancer types:
| 癌症種類 | 肥胖癌症風險增幅 | 主要機制 |
|---|---|---|
| 子宮內膜癌 | 高達 50% 病例與過重/肥胖相關 | 芳香酶過度活化，雌激素合成增加 |
| 停經後乳癌 | BMI 每增加 10 單位，風險上升約 40% | 脂肪組織雌激素合成＋慢性發炎 |
| 大腸直腸癌 | BMI 每增加 5 單位，風險增加 9–24%（依性別） | 腸道菌叢失衡＋高胰島素血症 |
| 胰臟癌 | 過重者風險較正常體重高 15–20% | 胰島素阻抗＋慢性胰腺發炎 |
| 肝癌 | 非酒精性脂肪肝（NAFLD）與肥胖高度共病 | 脂肪肝→纖維化→肝癌進程 |
| 腎臟癌 | BMI 每增加 5 單位，風險增加約 25% | 高胰島素血症＋脂肪因子失衡 |
兒童期及青少年期的肥胖同樣會在成年後顯現更高的肥胖癌症風險——早期的代謝異常會持續影響成年後的腫瘤發生環境。過重（BMI 25–29.9）本身也有風險，而非只有達到肥胖（BMI ≥ 30）才需擔心。
Obesity in childhood and adolescence manifests as higher obesity-cancer risk in adulthood — early metabolic abnormalities continuously shape the pro-tumor environment later in life. Overweight (BMI 25–29.9) also carries risk, not only full obesity (BMI ≥ 30).
📖 延伸閱讀：我適合減重手術嗎？三大關鍵適應症與正確時機
📖 Further reading: Am I a Candidate for Bariatric Surgery? Three Key Indications
肥胖如何促進癌症？五大生物機制 How Does Obesity Promote Cancer? Five Biological Mechanisms
肥胖並非直接「製造」癌細胞，而是悄悄改變身體的內部環境，讓腫瘤更容易生長。
Obesity doesn't directly "create" cancer cells — it quietly alters the body's internal environment, making it easier for tumors to grow.
JAMA 2026 研究整理出五大核心機制，解釋了肥胖與癌症的關係在生物學層面如何運作：
The JAMA 2026 study identifies five core mechanisms explaining how the obesity-cancer relationship operates at the biological level:
脂肪細胞過度增生時發生了什麼？
正常情況下，脂肪細胞負責儲存能量並分泌有益荷爾蒙（如脂聯素 adiponectin，具有抗腫瘤效果）。但當脂肪細胞過度增生肥大時，荷爾蒙分泌會出現以下異常：
- 瘦素（Leptin）↑：促進腫瘤細胞增殖
- 脂聯素（Adiponectin）↓：失去抑制腫瘤的保護力
- 芳香酶（Aromatase）↑：停經後女性雌激素合成增加，促進乳癌、子宮內膜癌
- 促炎細胞激素↑（IL-1β、IL-6、TNF-α）：慢性全身性發炎，助長腫瘤微環境
脂肪發炎的病理標誌
脂肪組織中出現「皇冠狀結構（crown-like structures）」——大量巨噬細胞包圍死亡脂肪細胞——是脂肪組織慢性發炎的病理標誌，在乳癌患者的脂肪組織中已被觀察到。
What Happens When Fat Cells Over-proliferate?
Under normal conditions, fat cells store energy and secrete beneficial hormones (such as adiponectin, which has anti-tumor effects). When fat cells over-proliferate, hormonal secretion becomes abnormal:
- Leptin ↑: promotes tumor cell proliferation
- Adiponectin ↓: loss of tumor-suppressing protection
- Aromatase ↑: increased estrogen synthesis in post-menopausal women, promoting breast and endometrial cancers
- Pro-inflammatory cytokines ↑ (IL-1β, IL-6, TNF-α): chronic systemic inflammation supporting the tumor microenvironment
The Pathological Hallmark of Fat Inflammation
"Crown-like structures" — clusters of macrophages surrounding dead fat cells — are the pathological hallmark of adipose tissue chronic inflammation, and have been observed in the breast tissue of cancer patients.
肥胖如何破壞 DNA？
肥胖會產生過量的活性氧自由基（ROS），直接攻擊 DNA，導致雙股斷裂（double-strand breaks）等嚴重損傷。
同時，肥胖會降低細胞的 DNA 修復能力，使突變無法被及時糾正，長期累積後便可能誘發肥胖相關癌症。
遺傳高風險族群尤須注意
研究發現，攜帶 BRCA1 或 BRCA2 基因突變的女性，BMI 越高，乳腺和輸卵管上皮細胞中積累的 DNA 損傷越多。這意味著肥胖癌症風險在有遺傳易感性者身上可能更為顯著。
How Does Obesity Damage DNA?
Obesity generates excessive reactive oxygen species (ROS) that directly attack DNA, causing double-strand breaks and other serious damage.
At the same time, obesity reduces the cell's DNA repair capacity, leaving mutations uncorrected. Long-term accumulation can trigger obesity-related cancers.
Especially Important for Genetically High-Risk Groups
Studies show that women carrying BRCA1 or BRCA2 mutations with higher BMI accumulate more DNA damage in breast and fallopian tube epithelial cells — suggesting that obesity-cancer risk may be especially pronounced in those with genetic susceptibility.
脂肪細胞直接提供腫瘤能量
肥胖者的脂肪細胞透過微小的「胞外囊泡（extracellular vesicles）」，將大量游離脂肪酸、蛋白質及 micro-RNA 轉移給周圍的癌細胞，直接為腫瘤提供生長所需的能量與訊號。
高胰島素血症促進癌細胞增殖
肥胖使得胰島素阻抗增加、血中胰島素濃度持續偏高，進一步刺激癌細胞的增殖訊號。
肥胖者體內 AMPK（腺苷酸活化蛋白激酶）活性降低，導致細胞更依賴葡萄糖代謝（Warburg 效應），為癌細胞快速分裂提供充足能量。
Fat Cells Directly Supply Tumor Energy
Fat cells in obese individuals transfer large amounts of free fatty acids, proteins, and micro-RNAs to surrounding cancer cells via tiny "extracellular vesicles," directly supplying the energy and signals needed for tumor growth.
Hyperinsulinemia Promotes Cancer Cell Proliferation
Obesity leads to increased insulin resistance and persistently elevated insulin levels, further stimulating proliferation signals in cancer cells.
AMPK activity is reduced in obese individuals, causing cells to rely more heavily on glucose metabolism (the Warburg effect), providing abundant fuel for rapidly dividing cancer cells.
肥胖如何削弱免疫監控能力？
正常免疫系統能偵測並清除早期癌細胞，但肥胖會從多個層面破壞這道防線：
- 自然殺手細胞（NK cell）數量減少、殺傷力下降
- 骨髓衍生抑制細胞（MDSC）大量聚集，壓制抗腫瘤免疫反應
- 細胞毒性 T 細胞（CD8⁺ T cell）功能受損，無法有效消滅癌細胞
- 巨噬細胞從「監視腫瘤」轉向「促進腫瘤修復/生長」的表型
對癌症治療的影響
這也說明了為何肥胖患者對部分癌症免疫治療的反應可能較差——肥胖本身已抑制了免疫系統的抗癌能力。
How Does Obesity Weaken Immune Surveillance?
The normal immune system detects and eliminates early cancer cells, but obesity disrupts this defense at multiple levels:
- Natural Killer (NK) cells: reduced numbers and decreased killing capacity
- Myeloid-Derived Suppressor Cells (MDSC): massive accumulation, suppressing anti-tumor immune responses
- Cytotoxic T cells (CD8⁺): impaired function, unable to effectively eliminate cancer cells
- Macrophages switch from "tumor surveillance" to a "tumor repair/growth promotion" phenotype
Impact on Cancer Treatment
This also explains why obese patients may respond less well to some cancer immunotherapy treatments — obesity has already suppressed the immune system's anti-cancer capacity.
肥胖改變腸道菌相
肥胖與腸道菌叢組成的改變密切相關。有保護作用的共生菌（如 Akkermansia muciniphila）減少，而具有促炎或致癌潛力的菌種（如 Bilophila）增加。
腸漏導致全身性慢性發炎
這種失衡會破壞腸道黏膜屏障，使細菌代謝物（如內毒素）進入血液，觸發全身性慢性發炎。
在大腸直腸癌患者中，特定促炎菌種的過度增殖已被多項研究證實與腫瘤發生有關。益生菌攝取可能有助於調整菌叢組成，但目前尚缺乏充分的臨床試驗數據。
Obesity Alters the Gut Microbiome
Obesity is closely linked to changes in gut microbiome composition. Beneficial commensal bacteria (such as Akkermansia muciniphila) decrease, while pro-inflammatory or potentially carcinogenic species (such as Bilophila) increase.
Gut Leakiness Leads to Systemic Chronic Inflammation
This imbalance disrupts the gut mucosal barrier, allowing bacterial metabolites (such as endotoxins) to enter the bloodstream, triggering systemic chronic inflammation.
In colorectal cancer patients, overproliferation of specific pro-inflammatory bacteria has been confirmed in multiple studies. Probiotic supplementation may help adjust microbiome composition, but sufficient clinical trial data is still lacking.
📖 延伸閱讀：代謝手術如何改善糖胖症及相關代謝疾病？
📖 Further reading: How Metabolic Surgery Improves Diabesity and Related Metabolic Diseases
減重能降低癌症風險嗎？最新實證 Can Weight Loss Reduce Cancer Risk? Latest Evidence
好消息是：減重確實可以降低肥胖癌症風險。研究顯示，體重減輕至少 5% 可以觀察到肥胖相關癌症發生率的下降，而減重超過 10% 效果更顯著。
The good news: weight loss does reduce obesity-cancer risk. Research shows that losing at least 5% of body weight produces an observable decline in obesity-related cancer incidence, with losses exceeding 10% showing more significant effects.
以下是各種減重方式的癌症預防實證比較：
Below is a comparison of cancer-prevention evidence for various weight loss approaches:
| 減重方式 | 平均減重幅度 | 癌症風險降低 | 證據強度 |
|---|---|---|---|
| 代謝減重手術 腹腔鏡微創 |
>20%（體重） | 10 年癌症發生率降低 32%（HR 0.68）；子宮內膜癌降幅尤其顯著 | 最強 |
| GLP-1 受體促效劑 如 semaglutide、tirzepatide |
10–15% | 與胰島素相比，10 種肥胖相關癌症風險下降；胰臟癌 HR 0.41，大腸癌 HR 0.47 | 良好（觀察性） |
| 生活型態介入 飲食控制 + 運動 |
4–6% | 3 年內體重減少 ≥5% → 肥胖相關癌症發生率明顯降低（HR 0.88） | 良好（觀察性） |
| Metformin（二甲雙胍） 第二型糖尿病用藥 |
2–3 kg | Meta 分析顯示整體癌症發生率降低（RR 0.65），但受發表偏誤影響 | 初步（待驗證） |
代謝手術防癌：目前最有效的減重防癌方式 Bariatric Surgery for Cancer Prevention: Currently the Most Effective Approach
根據一項逾 3 萬名 BMI ≥ 35 患者的大型觀察性研究，接受代謝減重手術者在 10 年後肥胖相關癌症的累積發生率為 2.9%，顯著低於未手術對照組的 4.6%——整體降低約 32%（HR 0.68）。
In a large observational study of over 30,000 patients with BMI ≥ 35, those who underwent metabolic bariatric surgery had a 10-year cumulative obesity-related cancer incidence of 2.9%, significantly lower than the 4.6% in the non-surgical control group — an overall reduction of approximately 32% (HR 0.68).
手術組的平均體重減少達 −27.5 kg，遠超過藥物治療所能達到的幅度。子宮內膜癌的降幅尤其顯著，代謝手術癌症風險的降低效果在婦科癌症中最為突出。
The surgical group lost an average of −27.5 kg, far exceeding what medication achieves. The reduction in endometrial cancer was particularly dramatic.
📖 延伸閱讀：我適合減重手術嗎？三大關鍵適應症
📖 Further reading: Am I a Candidate for Bariatric Surgery? Three Key Indications
GLP-1 減重針（瘦瘦針）與癌症風險 GLP-1 Weight Loss Injections & Cancer Risk
一項涵蓋逾 165 萬名第二型糖尿病患者的大型回溯性研究顯示，GLP-1 減重針癌症的相關數據令人振奮：與使用胰島素相比，使用 GLP-1 受體促效劑的患者在 10 種肥胖相關癌症上的風險均有下降。
A large retrospective study of over 1.65 million type 2 diabetes patients showed encouraging data: compared to insulin, patients using GLP-1 receptor agonists showed reduced risk across 10 obesity-related cancers.
然而，GLP-1 藥物停藥後的體重回升可能影響長期的癌症預防效果，仍需隨機對照試驗確認因果關係。
However, weight regain after stopping GLP-1 medications may affect long-term cancer prevention. Randomized controlled trials are still needed to confirm causality.
📖 延伸閱讀：SASJ 減重手術 vs 瘦瘦針：哪個適合我？（JAMA 實證比較）
📖 Further reading: SASJ Bariatric Surgery vs. GLP-1 Injections: Which Is Right for Me?
減重 10%：降低肥胖癌症風險的關鍵門檻 The 10% Threshold: Key to Reducing Obesity-Cancer Risk
癌症風險的顯著下降通常需要體重減少超過 10%。單純飲食控制或輕度運動（平均減重 4–6%）雖有幫助，但效果有限。
Significant cancer risk reduction generally requires losing more than 10% of body weight. Diet alone or mild exercise (average 4–6% weight loss), while helpful, has limited effect.
若要達到持久且足夠幅度的減重，對符合條件的患者，代謝手術或 GLP-1 藥物可提供更可靠的支持，也是目前降低肥胖癌症風險最有實證依據的方式。
For sustainable and sufficient weight loss, metabolic surgery or GLP-1 medications offer more reliable support for eligible patients, and are currently the most evidence-based approaches to reducing obesity-cancer risk.
⭐ 結語：減重是預防癌症的積極行動 ⭐ Conclusion: Weight Loss Is Active Cancer Prevention
肥胖不只是體重數字的問題——它是一個複雜的慢性疾病，透過發炎、荷爾蒙失調、DNA 損傷等機制，默默增加肥胖癌症風險。
Obesity is not just a number on the scale — it is a complex chronic disease that quietly increases obesity-cancer risk through inflammation, hormonal dysregulation, DNA damage, and other mechanisms.
- 🔬肥胖與 12 種肥胖相關癌症直接相關，每年有 10% 的新癌症診斷可歸因於肥胖
- ⚙️五大機制（發炎、DNA 損傷、能量代謝、免疫失衡、菌叢失調）共同促進腫瘤生長
- 📉減重超過 10% 可有效降低癌症風險，其中代謝手術的防癌效果最強，可將肥胖相關癌症發生率降低 32%
- 💊GLP-1 減重針癌症預防也顯示出初步效果，但仍需更多隨機試驗確認長期成效
- 🔬Obesity is directly linked to 12 obesity-related cancers; 10% of new cancer diagnoses annually are attributable to obesity
- ⚙️Five mechanisms (inflammation, DNA damage, energy metabolism, immune impairment, microbiome dysbiosis) collectively promote tumor growth
- 📉Losing more than 10% of body weight effectively reduces cancer risk; bariatric surgery offers the strongest effect, reducing obesity-related cancer incidence by 32%
- 💊GLP-1 weight loss injections also show preliminary cancer-prevention effects, but more randomized trials are needed to confirm long-term outcomes
如果您正面臨肥胖且擔心癌症風險，不要等待。主動尋求評估、選擇合適的減重方案，是保護自己最積極的行動。
If you are facing obesity and concerned about cancer risk, don't wait. Seeking evaluation and choosing an appropriate weight management approach is the most proactive step you can take to protect yourself.
🙋 常見問題 FAQ 🙋 Frequently Asked Questions
肥胖和哪些癌症有關？肥胖相關癌症有哪 12 種？
根據國際癌症研究機構（IARC）的認定，肥胖與以下 12 種癌症直接相關：
- 大腸直腸癌、子宮內膜癌、停經後乳癌、膽囊癌
- 腎臟癌、肝癌、食道癌（腺癌）、卵巢癌
- 胰臟癌、胃癌（賁門腺癌）、多發性骨髓瘤、甲狀腺癌
其中子宮內膜癌的肥胖癌症風險最高，多達 50% 的子宮內膜癌病例可歸因於過重或肥胖。
Which cancers are associated with obesity? What are the 12 obesity-related cancers?
According to the IARC, obesity is directly linked to these 12 cancers:
- Colorectal cancer, endometrial cancer, post-menopausal breast cancer, gallbladder cancer
- Kidney cancer, liver cancer, esophageal cancer (adenocarcinoma), ovarian cancer
- Pancreatic cancer, gastric cancer (cardia adenocarcinoma), multiple myeloma, thyroid cancer
Endometrial cancer carries the highest obesity-cancer risk — up to 50% of cases are attributable to overweight or obesity.
肥胖為什麼會提高癌症風險？BMI 與癌症有什麼關係？
肥胖透過五大機制促進癌症發生：
- 脂肪組織功能失調：慢性發炎、瘦素增加、脂聯素減少、雌激素合成增加
- DNA 損傷：活性氧自由基破壞基因，並降低 DNA 修復能力
- 能量代謝失調：脂肪細胞為癌細胞直接提供能量，高胰島素血症促進增殖
- 免疫功能受損：自然殺手細胞和 T 細胞功能下降，無法清除癌細胞
- 腸道菌叢失衡：保護菌減少、促炎菌增加，破壞腸道屏障
BMI 每增加 5 單位，大腸癌風險增加約 9–24%，停經後乳癌風險增加更顯著。
Why does obesity increase cancer risk? What is the relationship between BMI and cancer?
Obesity promotes cancer through five mechanisms:
- Adipose tissue dysfunction: chronic inflammation, increased leptin, decreased adiponectin, increased estrogen synthesis
- DNA damage: reactive oxygen species damage genes and reduce DNA repair capacity
- Altered energy metabolism: fat cells directly supply cancer cells with energy; hyperinsulinemia promotes proliferation
- Impaired immune function: NK cells and T cells function poorly, unable to clear cancer cells
- Gut microbiome dysbiosis: protective bacteria decrease, pro-inflammatory bacteria increase, gut barrier disrupted
BMI increases of 5 units raise colorectal cancer risk by 9–24%; post-menopausal breast cancer risk rises even more significantly.
減重手術防癌效果如何？代謝手術能降低多少癌症風險？
根據 JAMA 2026 年研究，BMI ≥ 35 且接受代謝減重手術的患者，10 年後肥胖相關癌症累積發生率為 2.9%，對照未手術組為 4.6%，整體降低約 32%（HR 0.68）。
手術後平均體重減少 −27.5 kg，代謝手術癌症風險降低效果遠超過藥物或生活型態介入。子宮內膜癌的降幅尤其顯著。
How effective is bariatric surgery for cancer prevention? How much does it reduce cancer risk?
In the JAMA 2026 study, patients with BMI ≥ 35 who underwent metabolic bariatric surgery had a 10-year cumulative obesity-related cancer incidence of 2.9%, versus 4.6% in the non-surgical group — an overall reduction of approximately 32% (HR 0.68).
Average weight loss was −27.5 kg, far exceeding what medication or lifestyle intervention achieves. The reduction in endometrial cancer was especially striking.
減重真的可以降低癌症風險嗎？要減多少才有效？
是的。研究顯示體重至少減少 5% 已可觀察到肥胖相關癌症發生率下降，但要達到具臨床意義的癌症風險降低，通常需要減重超過 10%。
目前最強的減重防癌證據來自代謝減重手術——一項逾 3 萬名患者的研究顯示，手術後 10 年肥胖相關癌症的發生率降低約 32%。GLP-1 受體促效劑也顯示出初步的防癌效果。
Can weight loss really reduce cancer risk? How much weight loss is needed?
Yes. Research shows that losing at least 5% of body weight can reduce obesity-related cancer incidence, but clinically meaningful cancer risk reduction typically requires losing more than 10%.
The strongest evidence comes from metabolic bariatric surgery — a study of over 30,000 patients showed a 32% reduction in obesity-related cancer incidence at 10 years. GLP-1 receptor agonists also show preliminary cancer-prevention effects.
GLP-1 減重針（瘦瘦針）對癌症風險有影響嗎？
初步研究顯示有益。一項涵蓋逾 165 萬名第二型糖尿病患者的大型回溯性研究發現，GLP-1 減重針癌症風險在 10 種肥胖相關癌症上均有下降，其中：
- 胰臟癌：危險比（HR）0.41
- 大腸直腸癌：HR 0.47
- 肝癌：HR 0.47
- 卵巢癌：HR 0.47
但目前這些數據來自觀察性研究，仍需要隨機對照臨床試驗才能確認因果關係。
Do GLP-1 weight loss injections affect cancer risk?
Initial research shows benefit. A large retrospective study of over 1.65 million type 2 diabetes patients found that GLP-1 receptor agonists were associated with reduced risk across 10 obesity-related cancers, including:
- Pancreatic cancer: Hazard Ratio (HR) 0.41
- Colorectal cancer: HR 0.47
- Liver cancer: HR 0.47
- Ovarian cancer: HR 0.47
However, these data come from observational studies. Randomized controlled trials are still needed to confirm causality.
想評估您的肥胖癌症風險？ Want to Assess Your Obesity-Cancer Risk?
門診可協助評估 BMI、代謝指標及肥胖相關癌症風險，並討論最適合您的減重方案——從生活型態調整到代謝手術防癌，由跨科別團隊提供個人化建議。
Our clinic can help evaluate your BMI, metabolic indicators, and obesity-related cancer risk, and discuss the most suitable weight management approach — from lifestyle changes to bariatric surgery for cancer prevention — with personalized recommendations from our multidisciplinary team.